(C) Reuters. Pfizer Earnings, Revenue Beat in Q2
Pfizer announced earnings per share of $0.78 on revenue of $11.80B. Analysts polled by Investing.com anticipated EPS of $0.68 on revenue of $11.58B.
Pfizer shares are down 4% from the beginning of the year , still down 12.70% from its 52 week high of $43.00 set on July 29, 2019. They are outperforming the Dow Jones which is down 6.85% from the start of the year.
Pfizer’s report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on Thursday with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Pfizer Earnings, Revenue Beat in Q2
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.